Jan 20 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.
Go-around describes the Federal Reserve's method for auctioning Treasury securities through primary dealers, a key part of its monetary policy strategy.
Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...